QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 6 filers reported holding QIAGEN NV in Q1 2017. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,953,000 | -9.0% | 69,689 | -11.0% | 0.06% | -9.7% |
Q3 2016 | $2,147,000 | +11.6% | 78,259 | -11.3% | 0.06% | +6.9% |
Q2 2016 | $1,924,000 | -41.3% | 88,239 | -39.9% | 0.06% | -38.3% |
Q1 2016 | $3,278,000 | -21.2% | 146,719 | -2.5% | 0.09% | -21.7% |
Q4 2015 | $4,161,000 | +16.4% | 150,489 | +8.6% | 0.12% | +8.1% |
Q3 2015 | $3,576,000 | +7.6% | 138,600 | +3.4% | 0.11% | +15.6% |
Q2 2015 | $3,323,000 | +16.6% | 134,043 | +18.6% | 0.10% | +20.0% |
Q1 2015 | $2,849,000 | +24.8% | 113,053 | +16.2% | 0.08% | +21.2% |
Q4 2014 | $2,282,000 | +93.9% | 97,253 | +88.1% | 0.07% | +65.0% |
Q3 2014 | $1,177,000 | -4.2% | 51,693 | +2.9% | 0.04% | +2.6% |
Q2 2014 | $1,228,000 | +11.6% | 50,243 | -3.7% | 0.04% | +14.7% |
Q1 2014 | $1,100,000 | -13.5% | 52,158 | -2.3% | 0.03% | -8.1% |
Q4 2013 | $1,271,000 | -16.4% | 53,378 | -24.9% | 0.04% | 0.0% |
Q3 2013 | $1,521,000 | +12.4% | 71,080 | +4.6% | 0.04% | +2.8% |
Q2 2013 | $1,353,000 | – | 67,960 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hardman Johnston Global Advisors LLC | 6,178,402 | $170,833,000 | 11.32% |
Tikvah Management LLC | 369,425 | $10,215,000 | 5.35% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 360,000 | $9,954,000 | 3.36% |
Opus Point Partners Management, LLC | 160,000 | $4,424,000 | 2.92% |
Exane Asset Management | 106,238 | $2,910,304,000 | 1.76% |
Douglas C. Lane & Associates, Inc. | 1,918,338 | $53,042,000 | 1.44% |
Granahan Investment Management | 1,051,000 | $29,060,000 | 1.00% |
CRAMER ROSENTHAL MCGLYNN LLC | 2,285,569 | $63,196,000 | 0.95% |
Sivik Global Healthcare LLC | 70,000 | $1,936,000 | 0.92% |
PURA VIDA INVESTMENTS, LLC | 78,668 | $2,175,000 | 0.92% |